Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Mevis Medical Sol.na

Start price
Target price
Perf. (%)
€30.80
23.12.21
-
23.12.22
3.25%
25.08.22

buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€484.00
23.12.21
-
23.12.22
-15.70%
25.08.22

buy
Maternus-Kliniken AG

Start price
Target price
Perf. (%)
€4.74
23.12.21
-
23.12.22
-50.21%
25.08.22

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€35.03
23.12.21
-
23.12.22
-28.09%
25.08.22

buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€629.00
24.08.21
-
24.08.22
-38.00%
24.08.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€126.20
24.08.21
-
24.08.22
-67.27%
24.08.22

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.91
13.08.22
€1.00
13.08.23
-12.70%
23.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€299.10
21.08.21
€325.00
21.08.22
-10.60%
22.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
Crossject S.A.

Start price
Target price
Perf. (%)
€2.82
18.11.21
€2.50
18.11.22
66.84%
16.08.22

Could be worthwhile Investment >10% per year
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€154.40
23.07.22
€170.00
23.08.22
5.63%
11.08.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
buy
Tandem Diabetes Care Inc

Start price
Target price
Perf. (%)
€91.50
10.08.21
-
10.08.22
-42.25%
10.08.22

Stratec SE

Start price
Target price
Perf. (%)
€85.00
26.07.22
€66.00
26.07.23
4.94%
06.08.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€147.00
01.02.22
€180.00
01.08.22
-3.71%
01.08.22

Could be very worthwhile Investment >20% year
Standard Investments for future growth
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.70
27.01.22
€42.00
27.07.22
-24.49%
27.07.22

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.50
26.07.21
-
26.07.22
-74.03%
27.07.22

Probably not worthwhile Investment
buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€480.00
25.07.21
€550.00
25.07.22
-18.33%
25.07.22

buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€155.00
15.07.23
5.64%
23.07.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
buy
Staar Surgical Co.

Start price
Target price
Perf. (%)
€103.15
08.11.21
-
08.11.22
-29.38%
21.07.22

buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€523.00
08.11.21
-
08.11.22
-29.64%
21.07.22

buy
Trupanion Inc.

Start price
Target price
Perf. (%)
€87.08
18.07.21
-
18.07.22
-27.35%
18.07.22

buy
Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€5.75
14.07.21
-
14.07.22
-68.30%
15.07.22

Could be worthwhile Investment >10% per year
buy
Ryman Healthcare Group Ltd.

Start price
Target price
Perf. (%)
€7.98
13.07.21
€10.00
13.07.22
-31.03%
13.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management
buy
Alpha Pro Tech Ltd.

Start price
Target price
Perf. (%)
€6.22
11.07.21
€12.00
11.07.22
-30.03%
12.07.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Small cyclical dependencies
Undervalued
CareCloud Inc.

Start price
Target price
Perf. (%)
€6.85
10.07.21
€3.20
10.07.22
-46.86%
11.07.22

Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Eckert & Ziegler BEBIG SA

Start price
Target price
Perf. (%)
-
14.09.21
€137.00
14.09.22
-
10.07.22

Could be worthwhile Investment >10% per year